MedCity News
Cellares gets $82M to make cell therapy manufacturing automated, scalable
Cell therapy manufacturing is currently a manual, multi-step process that takes weeks. Startup Cellares, which is developing a system that automates the process and makes manufacturing scalable, will use the Series B financing to accelerate its work.
Shares0
Talk to enough biotech industry folks and the phrase “the product is the process” is bound to come up. It refers to cell therapies, which are made by engineering human cells. In short, the medicine is an extension of the process that produced it. Today, that process is time consuming, mostly manual, and very expensive.
/PRNewswire/ Midwest Products & Engineering (MPE-INC), a leading design and contract manufacturer of medical devices, today announced their expansion into.
Craig Limoli, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Garry Welch, Author at MedCity News medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Covid-19 has demonstrated the grave need for us to invest in chronic disease prevention and support by building stronger, deeper relationships with patients and families, and by focusing more on the environmental, social, and psychological factors that lead to chronic disease and impact long-term disease management.